Cancer Literacy as an Essential Factor for Lifestyle Behavior Changes: An Observational and Interventional Study

NCT06614673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1422

Last updated 2025-06-15

No results posted yet for this study

Summary

The CLARO study aims to examine the most effective way to design information materials that can strengthen optimistic beliefs about cancer prevention and improve cancer literacy indirectly. Around 5,800 participants from the Stuttgart region in Germany will be contacted by postal mail and invited to take part in an online survey using the LimeSurvey®-System. Four different types of information materials, tested in a pilot study (2x2-design: text or animation-based / narrative or non-narrative), will be included in the survey. Participants will be randomly assigned to one of the four interventions or to a control group that will not receive any intervention (the control group will have access to all information materials after having completed the whole questionnaire). As an incentive, participants will receive 10€ via bank transfer upon completing the survey.

Conditions

  • Cancer Prevention

Interventions

OTHER

text in non-narrative form

Participants will be asked to read a text and complete questionnaires

OTHER

text in narrative form

Participants will be asked to read a text and complete questionnaires

OTHER

animated video in non-narrative form

Participants will be asked to watch a video and complete questionnaires

OTHER

animated video in narrative form

Participants will be asked to watch a video and complete questionnaires

Sponsors & Collaborators

  • University of Music, Drama, and Media Hannover

    collaborator UNKNOWN
  • German Cancer Research Center

    lead OTHER

Principal Investigators

  • Karen Steindorf, Prof. Dr. · German Cancer Research Center

  • Alexander Haussmann, Dr. · German Cancer Research Center

  • Florian Herbolsheimer, Dr. · German Cancer Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-30
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614673 on ClinicalTrials.gov